CV CapsoVision
NEUTRAL
Impact: 3/10
PRESS-RELEASE
Press release: earnings
Latest settled — T+20d
CV ▲ +17.03% at T+20d
NEUTRAL call ✓ call won +17.03% · α vs SPY +13.44% · entry $5.52 → $6.46
Currently $6.47 · +17.21% from $5.52 entry
T+1d
-6.88%
call -6.88% · α -7.91%
$5.14
settled 2mo ago
T+5d
+24.46%
call +24.46% · α +26.57%
$6.87
settled 2mo ago
T+20d
+17.03%
call +17.03% · α +13.44%
$6.46
settled 6w ago
T+60d
—
call — · α —
—
in 18d
Price Chart
Loading chart...
Executive Summary
CapsoVision announced it will release its Q4 and full-year 2025 financial results on March 26, 2026, followed by a conference call. The press release contains no actual financial data, serving only as a preview of the upcoming earnings announcement.
Actionable Insight
Traders should prepare for potential volatility following the March 26 earnings release and call, particularly focusing on revenue trends, cash burn, and progress toward commercial adoption of its AI-enhanced capsule technology.
Key Facts
- CapsoVision will release Q4 and full-year 2025 financial results on March 26, 2026, after market close.
- A conference call and webcast are scheduled for the same day at 1:30 pm PT / 4:30 pm ET.
- No financial results, guidance, or operational updates were disclosed in this release.
- The company remains focused on its AI-enabled capsule endoscopy platform, including CapsoCam Plus® and the pipeline product CapsoCam Colon™.
Financial Impact
No financial data disclosed
Risk Factors
- Limited liquidity or high cash burn could raise near-term solvency concerns if disclosed in the upcoming report.
- Failure to show meaningful revenue growth or clinical adoption may pressure the stock despite the AI narrative.
Market Snapshot
Exchange
Nasdaq
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3255094 |
6 reports for CV
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Apr 30, 2026
20d ago
|
Press Release
| $7.50 $7.19 | ▼ −4.13% | ▼ −6.48% | $6.47 (−13.73%) |
|
Apr 23, 2026
28d ago
|
EFFECT
| $5.77 $6.40 | ▲ +10.92% | ▲ +9.44% | $6.47 (+12.13%) |
|
Apr 17, 2026
4w ago
|
S-1
| $6.01 $6.37 | ▲ +5.99% | ▲ +5.08% | $6.47 (+7.65%) |
|
Mar 26, 2026
7w ago
|
Press Release
| $7.51 $6.70 | ▼ −10.79% | ▼ −14.65% | $6.47 (−13.85%) |
|
Mar 20, 2026
8w ago
|
Press Release
| $6.87 $7.51 | ▲ +9.32% | ▲ +11.47% | $6.47 (−5.82%) |
|
Mar 12, 2026
9w ago
|
Press Release
| $5.52 $6.87 | ▲ +24.46% | ▲ +26.57% | $6.47 (+17.21%) |
Showing 6 of 6
US Market Status
Market Open — Closes in 3h 57m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access